Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman PrimatesKizzmekia S. Corbett, Alicia T. Widge, Kevin W. Bock et al.|New England Journal of Medicine|2020Cited by 1.2k
Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Pratap Kunwar, Sarah O’Connell et al.|Science|2021Cited by 602
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Nicole A. Doria‐Rose, Tongqing Zhou et al.|Science|2021Cited by 216
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trialJoseph P. Casazza, Maria Claudia Burgos Florez, Evan M. Cale et al.|Nature Medicine|2022Cited by 94